Successful Lung Transplantation for Severe Post-COVID-19 Pulmonary Fibrosis

Lung transplantation has been well described for patients with coronavirus disease 2019 (COVID-19) in the acute setting, but less so for the resulting pulmonary sequelae. This report describes a case of lung transplantation for post–COVID-19 pulmonary fibrosis. A 52-year-old woman contracted COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, David J., Schulte, Jefree J., Lewis, Erik E., Bommareddi, Swaroop R., Rohrer, Charles T., Sultan, Samir, Maloney, James D., DeCamp, Malcolm M., McCarthy, Daniel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by The Society of Thoracic Surgeons 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570389/
https://www.ncbi.nlm.nih.gov/pubmed/34748736
http://dx.doi.org/10.1016/j.athoracsur.2021.10.004
Descripción
Sumario:Lung transplantation has been well described for patients with coronavirus disease 2019 (COVID-19) in the acute setting, but less so for the resulting pulmonary sequelae. This report describes a case of lung transplantation for post–COVID-19 pulmonary fibrosis. A 52-year-old woman contracted COVID-19 in July 2020 and mounted a partial recovery, but she went on to have declining function over the ensuing 3 months, with development of fibrocystic lung changes. She underwent bilateral lung transplantation and recovered rapidly, was discharged home on postoperative day 14, and has done well in follow-up. This case report demonstrates that lung transplantation is an acceptable therapy for post–COVID-19 pulmonary fibrosis.

Ejemplares similares